Table of Contents Author Guidelines Submit a Manuscript
Developmental Immunology
Volume 7, Issue 2-4, Pages 143-153

In Vitro Studies on the Trafficking of Dendritic Cells Through Endothelial Cells and Extra-Cellular Matrix

1lstituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, Milan 20157 , Italy
2Dept. Biotechnology, Section of General Pathology, University of Brescia, Italy

Copyright © 2000 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Ae Lokshin, E Gorelik, Rb Mailliard, Am Marrangoni, J Muller-Berghaus, Rp Edwards, P Kalinski, Rr Sassi, Wj Storkus, and Xj Peng, “Differential regulation of maturation and apoptosis of human monocyte-derived dendritic cells mediated by MHC class II,” International Immunology, vol. 14, no. 9, pp. 1027–1037, 2002. View at Publisher · View at Google Scholar
  • J Bernard, Jc Eymard, D Ittelet, F Villard, P Jeannesson, and P Hollender, “Active matrix metalloprotease-9 in and migration pattern of dendritic cells matured in clinical grade culture conditions,” Immunobiology, vol. 206, no. 4, pp. 441–458, 2002. View at Publisher · View at Google Scholar
  • Kt Whelan, Cl Lin, M Cella, Aj McMichael, Jm Austyn, and Sl Rowland-Jones, “The HIV protease inhibitor Indinavir reduces immature dendritic cell transendothelial migration,” European Journal Of Immunology, vol. 33, no. 9, pp. 2520–2530, 2003. View at Publisher · View at Google Scholar
  • Bridget L. Colvin, Audrey H. Lau, Amanda M. Schell, and Angus W. Thomson, “Disparate ability of murine CD8alpha- and CD8alpha+ dendritic cell subsets to traverse endothelium is not determined by differential CD11b expression,” Immunology, vol. 113, no. 3, pp. 328–337, 2004. View at Publisher · View at Google Scholar
  • M Weis, Cl Schlichting, and Wd Schareck, “Dendritic cell endothelium interaction in autoimmunity,” Current Pharmaceutical Design, vol. 10, no. 2, pp. 171–181, 2004. View at Publisher · View at Google Scholar
  • Gerben Bouma, Jojanneke M. C. Coppens, Sabine Mourits, Tatjana Nikolic, Silvano Sozzani, Hemmo A. Drexhage, and Marjan A. Versnel, “Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice,” European Journal of Immunology, vol. 35, no. 8, pp. 2386–2396, 2005. View at Publisher · View at Google Scholar
  • Yuk Yuen Lan, An De Creus, Bridget L. Colvin, Masanori Abe, Volker Brinkmann, P. Toby H. Coates, and Angus W. Thomson, “The Sphingosine-1-Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In Vivo,” American Journal of Transplantation, vol. 5, no. 11, pp. 2649–2659, 2005. View at Publisher · View at Google Scholar
  • M. Weis, C. L. Schlichting, W. D. Schareck, and S. Kofler, “Involvement of dendritic cells in allograft rejection new implications of dendritic cell-endothelial cell interactions,” Mini-Reviews In Medicinal Chemistry, vol. 7, no. 4, pp. 423–428, 2007. View at Publisher · View at Google Scholar
  • E. Mazzon, E. Esposito, R. Di Paola, C. Mui, C. Crisafulli, T. Genovese, R. Caminiti, R. Meli, P. Bramanti, and S. Cuzzocrea, “Effect of tumour necrosis factor- receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept,” Clinical & Experimental Immunology, vol. 153, no. 1, pp. 136–149, 2008. View at Publisher · View at Google Scholar
  • Divya Sagar, Catherine Foss, Rasha Baz, Martin G. Pomper, Zafar K. Khan, and Pooja Jain, “Mechanisms of Dendritic Cell Trafficking Across the Blood–brain Barrier,” Journal of Neuroimmune Pharmacology, vol. 7, no. 1, pp. 74–94, 2011. View at Publisher · View at Google Scholar
  • Tomas Büchler, Jaroslav Michalek, Lucie Kovarova, Romana Musilova, and Roman Hajek, “Dendritic Cell-based Immunotherapy for the Treatment of Hematological Malignancies,” Hematology, vol. 8, no. 2, pp. 97–104, 2013. View at Publisher · View at Google Scholar
  • Manglio Rizzo, Juan Bayo, Flavia Piccioni, Mariana Malvicini, Esteban Fiore, Estanislao Peixoto, Mariana G. Garcia, Jorge B. Aquino, Ariel Gonzalez Campana, Gustavo Podesta, Marcelo Terres, Oscar Andriani, Laura Alaniz, and Guillermo Mazzolini, “Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Daniela D'Arcangelo, Ezio M. Nicodemi, Stefania Rossi, Claudia Giampietri, and Francesco Facchiano, “Identification of Serum Regression Signs in Infantile Hemangioma,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Yu Li, Qingsong Xu, Peng Wei, Likun Cheng, Qiang Peng, Shuguang Li, Heng Yin, and Yuguang Du, “Chitosan oligosaccharides downregulate the expression of E-selectin and ICAM-1 induced by LPS in endothelial cells by inhibiting MAP kinase signaling,” International Journal of Molecular Medicine, vol. 33, no. 2, pp. 392–400, 2014. View at Publisher · View at Google Scholar
  • Sussan Nourshargh, Stephen A. Renshaw, and Beat A. Imhof, “Reverse Migration of Neutrophils: Where, When, How, and Why?,” Trends in Immunology, 2016. View at Publisher · View at Google Scholar
  • Sarah C. Krzastek, Ekaterine Goliadze, Shaoqing Zhou, Albert Petrossian, Fatma Youniss, Gobalakrishnan Sundaresan, Li Wang, Jamal Zweit, and Georgi Guruli, “Dendritic cell trafficking in tumor-bearing mice,” Cancer Immunology, Immunotherapy, 2018. View at Publisher · View at Google Scholar
  • Maxime De Laere, Zwi N Berneman, and Nathalie Cools, “To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis,” Journal of Neuropathology & Experimental Neurology, 2018. View at Publisher · View at Google Scholar